Peter Klein
DirectoratDenali Therapeutics· In the 2025 proxy
Peter Klein sits on 1 public board.
Boards1
- Denali TherapeuticsDirector · 7 yr on the boardIndependentAudit (Chair), Compensation—Paid as an executive
Board seats come from each company's latest proxy statement.
Experience
- Denali TherapeuticsPublic company · 1 yr
- Director2025 – Present · 1 yrStock in role -8%
Roles come from the proxy statements of each company.
Activity
No new filings about this person in the feed.
Two people shown as one, or a wrong number?